Cardinal Health, Inc. (CAH) To Go Ex-Dividend on April 1st

Cardinal Health, Inc. (NYSE:CAH) announced a quarterly dividend on Thursday, February 12th. Shareholders of record on Wednesday, April 1st will be paid a dividend of 0.5107 per share on Wednesday, April 15th. This represents a c) annualized dividend and a yield of 0.9%. The ex-dividend date is Wednesday, April 1st.

Cardinal Health has increased its dividend payment by an average of 0.0%per year over the last three years and has raised its dividend every year for the last 29 years. Cardinal Health has a dividend payout ratio of 22.5% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Cardinal Health to earn $8.95 per share next year, which means the company should continue to be able to cover its $2.04 annual dividend with an expected future payout ratio of 22.8%.

Cardinal Health Stock Up 2.6%

CAH opened at $220.72 on Friday. The company has a market capitalization of $51.94 billion, a PE ratio of 31.76, a price-to-earnings-growth ratio of 1.39 and a beta of 0.64. The firm has a 50-day simple moving average of $208.84 and a two-hundred day simple moving average of $182.20. Cardinal Health has a 52 week low of $120.72 and a 52 week high of $230.81.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, February 5th. The company reported $2.63 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.31 by $0.32. Cardinal Health had a negative return on equity of 92.50% and a net margin of 0.68%.The firm had revenue of $65.63 billion for the quarter, compared to analysts’ expectations of $64.88 billion. During the same period in the previous year, the firm posted $1.93 earnings per share. The business’s revenue was up 18.8% compared to the same quarter last year. As a group, sell-side analysts expect that Cardinal Health will post 7.95 earnings per share for the current year.

Trending Headlines about Cardinal Health

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Recent quarterly results and underlying strength — Cardinal reported a Q4 EPS beat and revenue above expectations, with revenue up ~19% year-over-year, which analysts cite as supporting the stock’s upside. Cardinal Health’s (NYSE:CAH) Solid Earnings Are Supported By Other Strong Factors
• Positive Sentiment: Dividend confirmed — the Board approved a quarterly dividend of $0.5107 per share (payable Apr 15; record Apr 1). The cash return reinforces income appeal and signals confidence in cash flow. Cardinal Health Board of Directors Approves Quarterly Dividend
• Positive Sentiment: Analyst lift — JPMorgan raised its price target to $243, providing a tangible upside anchor for investors and helping sentiment. JPMorgan Chase Increases Cardinal Health Price Target
• Positive Sentiment: Zacks momentum & valuation coverage — CAH was added to Zacks’ Rank #1 momentum list and several Zacks pieces highlight undervaluation and a favorable long-term value case, which can attract momentum and value investors. Best Momentum Stock to Buy for February 13th Are Investors Undervaluing Cardinal Health?
• Neutral Sentiment: Kalkine notes logistics/reliability improvements on the NYSE composite — operational reliability updates are constructive but are incremental near-term drivers. Cardinal Health Boosts Logistics Reliability
• Neutral Sentiment: Analyst Q&A from the earnings call — the transcript highlights management’s priorities and risk items; useful for longer-term fundamental assessment but not an immediate catalyst. The 5 Most Interesting Analyst Questions From Cardinal Health’s Q4 Earnings Call

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.